Analysts Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $63.67

Astrana Health, Inc. (NASDAQ:ASTH) has earned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $63.67.

ASTH has been the topic of several research reports. Truist Financial dropped their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday, January 13th. Macquarie raised shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Finally, Robert W. Baird upped their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th.

Astrana Health Stock Performance

Shares of ASTH opened at $38.04 on Wednesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health has a one year low of $29.08 and a one year high of $63.20. The company has a 50-day simple moving average of $35.35 and a two-hundred day simple moving average of $45.61. The firm has a market capitalization of $2.14 billion, a PE ratio of 29.26, a price-to-earnings-growth ratio of 1.37 and a beta of 1.20.

Hedge Funds Weigh In On Astrana Health

Hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC bought a new position in Astrana Health in the 3rd quarter worth about $34,000. Nisa Investment Advisors LLC bought a new position in Astrana Health in the 3rd quarter valued at approximately $35,000. KBC Group NV purchased a new stake in Astrana Health during the 3rd quarter valued at $70,000. Quarry LP bought a new stake in shares of Astrana Health in the 3rd quarter worth $77,000. Finally, Quest Partners LLC purchased a new position in shares of Astrana Health in the third quarter worth $133,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.